Clinical applications of mouse models for breast cancer engaging HER2/neu. - Test2 - elhamkhani - TriplyDB

Clinical applications of mouse models for breast cancer engaging HER2/neu.

Clinical applications of mouse models for breast cancer engaging HER2/neu.

http://www.wikidata.org/entity/Q37607675

about

Cancer immunoprevention: from mice to early clinical trials.

P2860

Q55472478-37080A64-BAA2-4DF9-A67B-3C006752FDCC

P2860

Clinical applications of mouse models for breast cancer engaging HER2/neu.

http://www.wikidata.org/entity/Q37607675

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinical applications of mouse models for breast cancer engaging HER2/neu.

@en

Clinical applications of mouse models for breast cancer engaging HER2/neu.

@nl

type

label

Clinical applications of mouse models for breast cancer engaging HER2/neu.

@en

Clinical applications of mouse models for breast cancer engaging HER2/neu.

@nl

prefLabel

Clinical applications of mouse models for breast cancer engaging HER2/neu.

@en

Clinical applications of mouse models for breast cancer engaging HER2/neu.

@nl

P1433

Q37607675-D7EFE66D-9B82-499D-8039-1569851F8B7D

P1476

Q37607675-4490FC7C-5073-49D5-B69C-D8D44B42BA60

P2093

Q37607675-37426331-FB67-40B1-9E0F-89DC2222EB28

Q37607675-5545F0D7-B917-4611-A449-338DD8F412E9

Q37607675-9016C5E5-46D9-4445-9653-904A1DC892F4

P2860

Q37607675-007201CB-4104-4A71-B531-7CE443452F54

Q37607675-02458DD3-7684-4A56-BD34-5A386FCEE40C

Q37607675-02D7AE1B-EBD1-4221-A344-4B82FA35CDF2

Q37607675-03BDBEDE-5E04-4C74-A1FB-581D974FA1EB

Q37607675-08E8CE36-2747-4793-AD0B-8BBE79EDB7A3

Q37607675-090E4265-26BA-4D14-AF27-F1035B707491

Q37607675-09590378-6ED2-45E9-8D85-0283B3A5616A

Q37607675-09641C01-6252-4673-8149-3B47EA29E99A

Q37607675-09C906A3-DB29-44CE-A583-EE28D20A6331

Q37607675-0AC2FFDA-EA90-4629-91A0-D4A4755394E1

P304

Q37607675-22C9F069-2FB8-4D28-9716-02DB0BD7B490

P31

Q37607675-F380A865-1A48-4C98-A44F-184C64072FD1

P356

Q37607675-EE33B65E-CBB5-4885-B7D1-18BC43650F50

P433

Q37607675-4B60B317-19BD-431C-82DF-E10B6C17B5F5

P478

Q37607675-FF327C18-A667-4EBE-B78A-44992666AEC1

P577

Q37607675-51D78B06-9E83-4640-A0F3-282285E8CA13

P698

Q37607675-66A9C7DE-0CAD-4CEA-B341-DB41F75B781C

P932

Q37607675-C7F89D6D-FCC1-45F3-8C6E-D8901866D9D6

P356

P1433

Integrative cancer science and therapeutics

P1476

Clinical applications of mouse models for breast cancer engaging HER2/neu.

@en

P2093

Elizabeth A Fry

http://www.w3.org/2001/XMLSchema#string

Kazushi Inoue

http://www.w3.org/2001/XMLSchema#string

Pankaj Taneja

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients

Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK

Alphavirus replicon particles containing the gene for HER2/neu inhibit breast cancer growth and tumorigenesis.

Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model

Prime-boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu+ metastatic breast cancer in mice.

Wnt5a Signaling in Cancer

TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance

Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer

Role of EMT in Metastasis and Therapy Resistance

Epithelial-Mesenchymal Transition and Breast Cancer

P304

593-603

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15761/ICST.1000210

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28133539

http://www.w3.org/2001/XMLSchema#string

P932

5267336

http://www.w3.org/2001/XMLSchema#string